When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome de Wolff-Parkinson-White

Last reviewed: 8 Feb 2026
Last updated: 24 Sep 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presencia de factores de riesgo
  • taquicardia por reentrada auriculoventricular (TRAV)
Full details

Other diagnostic factors

  • palpitaciones
  • mareos
  • disnea
  • dolor torácico
  • fibrilación auricular
  • aleteo auricular
  • anomalías cardíacas congénitas
  • muerte cardíaca súbita
  • síncope y presíncope
  • taquicardia en el embarazo
Full details

Risk factors

  • Anomalía de Ebstein
  • cardiomiopatía hipertrófica
  • prolapso de la válvula mitral
  • comunicación interauricular
  • comunicación interventricular
  • transposición de los grandes vasos
  • coartación aórtica
  • dextrocardia
  • divertículos del seno coronario
  • aneurismas de la aurícula izquierda y derecha
  • rabdomiomas cardíacos
  • síndrome de Marfan
  • ataxia de Friedreich
  • antecedentes familiares
Full details

Diagnostic tests

1st tests to order

  • electrocardiograma (ECG) de 12 derivaciones
Full details

Tests to consider

  • ecocardiograma
  • prueba de esfuerzo
  • estudio electrofisiológico
Full details

Treatment algorithm

INITIAL

inestable: presión arterial <90/60 mmHg, signos de hipoperfusión sistémica o fibrilación auricular inestable

ACUTE

estable: taquicardia de complejo estrecho (ortodrómica de intercambio auriculoventricular)

estable: taquicardia de complejo ancho (antidrómica de intercambio auriculoventricular)

estable: taquicardia con preexcitación por fibrilación auricular o aleteo auricular

estable: taquicardia con preexcitación por taquicardia auricular

ONGOING

tras tratamiento agudo: asintomático

tras tratamiento agudo: sintomático

Contributors

Authors

Hugh Calkins, MD

Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

HC declares that he is a consultant for Medtronic, Biosense Webster, Abbott, and Boston Scientific.

Acknowledgements

We would like to acknowledge our cardiology expert panel member, Dr Fred Kusumoto, for his contribution to this topic.

Professor Hugh Calkins would like to gratefully acknowledge Dr David Frankel, Dr Mithilesh K. Das, and Dr Douglas P. Zipes, previous contributors to this topic.

Disclosures

DF, MKD, and DPZ declare that they have no competing interests.

Peer reviewers

Nicolas Palaskas, MD, FACC

Assistant Professor

University of Texas MD Anderson Cancer Center

Houston

TX

Disclosures

NP declares that he has no competing interests.

Joseph E. Marine, MD

Associate Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

JEM declares that he has no competing interests.

Suneet Mittal, MD

Director

Electrophysiology Laboratory

The St. Luke's-Roosevelt Hospital Center

New York

NY

Disclosures

SM declares that he has no competing interests.

Andrew Turley, MB ChB

Cardiology Specialist Registrar

The James Cook University Hospital

Middlesbrough

UK

Disclosures

AT declares that he has no competing interests.

Steve Hsu, MD

Associate Professor

Department of Medicine

Division of Cardiology

University of Florida College of Medicine

Jacksonville

FL

Disclosures

SH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Full text  Abstract

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.Full text  Abstract

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27-e115.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Síndrome de Wolff-Parkinson-White images
  • Differentials

    • Vía auriculofascicular
    • Síndrome de Lown-Ganong-Levine
    • Vía nodofascicular
    More Differentials
  • Guidelines

    • 2023 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    More Guidelines
  • პაციენტის ბროშურები

    Fibrilación auricular: ¿cuáles son las opciones de tratamiento?

    Fibrilación auricular: ¿qué es?

    მეტი პაციენტის ბროშურები
  • padlock-lockedშედით სისტემაში ან გამოიწერეთ BMJ Best Practice

ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას